Blitz Bureau NEW DELHI: Indian pharma market (IPM) has seen a 7.4 per cent year-on-year (YoY) growth in April due to a surge in chronic therapies, according to a report. The monthly report by Motilal Oswal Financial Services showed that the IPM’s growth in April 2024 was 9 per cent. In March 2025 it was…
…
A platform for change and progress. At Blitz India Business, our vision is to be a transformative platform that elevates the role of business and industry in driving India’s journey towards Viksit Bharat 2047. We are dedicated to fostering innovation, championing sustainability, and promoting inclusivity, while building a bridge for collaboration and progress.
Quick Links
Get important news delivered directly to your inbox and stay connected!